IMPORTANT NOTE: Medication errors have occurred between LAMICTAL and other medications, most commonly Lamisil®,* lamivudine, Ludiomil®,* labetalol, and Lomotil®.* Patients who do not receive LAMICTAL would be inadequately treated and could experience serious consequences. Conversely, patients erroneously receiving LAMICTAL, especially high initial doses, would be unnecessarily subjected to a risk of serious side effects.
*Lamisil (terbinafine HCl tablets) and Ludiomil (maprotiline HCl) are registered trademarks of Novartis Pharmaceuticals Corporation. Lomotil (diphenoxylate HCl, atropine sulfate) is a registered trademark of G.D. Searle LLC.
|
